Major Cancer Biology Students 2018

16. October 2018: Welcome to DKFZ!

© dkfz.de

already attending the FCR Conference at DKFZ (October 9-11)!

© dkfz.de

Sanjana BALAJI (India)

Alina BOLLHAGEN (Germany)

© dkfz.de

University Education
10/2015 – 09/2018: B.Sc. Biological Sciences at the University of Constance, Germany
10/2018 – present: M.Sc. Molecular Biosciences, Major Cancer Biology at the German Cancer Research Centre (DKFZ), Heidelberg, Germany

Highest Degree: Bachelor of Science (Biology)
Title of Bachelor Thesis
Characterization of the interaction between AIPL1, FAT10 and FAT10 substrates

Internship
07/15 – 08/15: Internship at the patent attorney's office Schiweck Weinzierl Koch GbR, München

Scientific Interests/Future Plans
Heterogeneity. This might be the best word to describe cancer, not only referring to its cell composition, but also to the variety of involved pathways. By covering a wide range of different subjects, cancer research is located at the interface of clinical medicine and fundamental research besides being one of the most relevant topics in a world of rising life expectancy. As I became especially interested in cell biology, immunology and biochemistry during my bachelor studies, I am now looking forward to combining these interests in an unique manner. I think that the power of our own immune system is a very elegant way to fight cancer. Here, I am especially interested in applying underlying immunological mechanisms in personalized medicine as e.g. CAR-T cells. In future, I envision myself as a PhD in the field of tumor immunology aiming for an academic career and life without cancer.

Contact: a.bollhagen (at) dkfz.de​

Maria BOULOUGOURI (Greece)

University Ecuation
15/10/2015-26/07/2018: Ruprecht-Karls University Heidelberg, Biosciences

Highest Degree: Bachelor of Science
Title of Bachelor Thesis:
The role of redox proteins in translation control

Scientific Interests/Future Plans
Despite encountering numerous cellular processes during my undergraduate studies, it is oncogenesis that intrigues me the most. The staggering variability in those affected, as pertains to factors such as age, sex and exposure to risk factors, seems to be one of the characteristics particular to cancer and highlights to me the complexity of this disease. No less captivated am I by the phenomenal variability of cancer itself, the sheer number of different signaling pathways that result in the same physiological reaction. Over the course of this program, I hope to learn more about the various signaling networks, whose disruption is associated with the emergence of this vicious disease. I'm particularly interested in pathway components, which could potentially be used as biomarkers in diagnostics or in the development of therapeutics, as, in the future, I hope to contribute to a better collective understanding of the molecular mechanisms behind cancer, as well as to the development of translational research. ​

Contact: m.boulougouri (at) dkfz.de

Alicia BUCK (Germany)

© dkfz.de

University Education
10/2018 – present: M.Sc. in Molecular Biosciences, Major Cancer Biology at Ruprecht-Karls University Heidelberg and German Cancer Research Center (DKFZ, Heidelberg)
02/2016 – 07/2016: semester abroad at Nelson Mandela University in Port Elizabeth, South Africa
10/2014 – 08/2018: B.Sc. in Biomedical Sciences at Reutlingen University

Highest Degree: Bachelor of Science (B.Sc.) in Biomedical Sciences
Title of Bachelor Thesis
Reactive Oxygen Species from Phagocytic Cells as Regulators of Inflammation – Evaluation of Pharmacological NADPH-Oxidase Inhibitors

Internships/Working Experience
03/2018 – 08/2018: Bachelor thesis "Reactive Oxygen Species from Phagocytic Cells as Regulators of Inflammation – Evaluation of Pharmacological NADPH-Oxidase Inhibitors" in the group of Prof. Dr. Johan Bylund, Department of Oral Microbiology and Immunology, University of Gothenburg, Sweden
02/2017 – 08/2017: Internship "KP1339, a Ruthenium Drug, that Interferes with ER Homeostasis" in the group of Dr. Petra Heffeter, Institute of Cancer Research, Medical University Vienna, Austria

Scientific Interests/Future Plans
Cancer cells are an unique entity throughout the body, not only because of the complexity of characteristics they entail but also due to the variety of mechanisms they utilize to evade the immune system or other control pathways of the human body. This complexity that not only covers one research area but includes several fields of biomedical research, as well as the cleverness of this cell type fascinates me most about cancer research. I am excited to get a deeper understanding of the pathways they tackle, the mechanisms that underlay tumorigenesis and of course how this fundamental research can get translated into clinical practice for cancer treatment. I am very passionate about science and am deeply convinced that cancer research offers great progress in future years. I am eager to contribute to that process while continuing towards a PhD and an academic career in an interdisciplinary environment in medical research.

Contact: a.buck (at) dkfz.de
LinkedIn profile

Maximiliane FINKBEINER (Germany)

© dkfz.de

University Education
10/2018 - present: M.Sc. Molecular Biosciences, Major Cancer Biology at Ruprecht-Karls-Universität Heidelberg, Germany and German Cancer Research Centre (DKFZ), Heidelberg, Germany
10/2015 - 07/2018: B.Sc. Biosciences at Ruprecht-Karls-Universität Heidelberg, Germany

Highest Degree: BSc in Biosciences
Title of Bachelor Thesis
Clonal Analysis of Adult Neural Stem Cells

Internships/Working Experience
03/2018 – 09/2018: Internship at the Division of Molecular Neurobiology headed by Prof. Dr. Ana Martin-Villalba at German Cancer Research Centre (DKFZ), Heidelberg, Germany

Scientific Interests/Future Plans
I developed a fascination for cancer research during my past studies. I'm excited by the possibilities and approaches in prevention, diagnosis and treatment of cancer and the clinical application to use results from basic research directly in clinic. My main motivation is to be able to contribute to progress in basic research and thereby contributing to the cure and rehabilitation of patients. I am thrilled to get the chance and opportunity to study in the interdisciplinary environment of the German Cancer Research Centre (DKFZ) and to be able to acquire a deeper understanding of cancer biology and the causes and mechanisms of carcinogenesis. My goal is to be able to pursue a future career in the field of cancer research and biomedicine.

Contact: m.finkbeiner (at) dkfz.de
LinkedIn profile

Alessia FLOERCHINGER (Germany & Switzerland)

© dkfz.de

University Education
10/18 – present: Master of Science: Molecular Biosciences with Major Cancer Biology, University of Heidelberg and German Cancer Research Center (DKFZ), Germany
10/15 – 09/18: Bachelor of Science: Molecular Medicine, University of Freiburg, Germany

Highest Degree: Bachelor of Science in Molecular Medicine
Title of Bachelor Thesis
Monitoring Rac1 as a potential therapeutic target in metastatic breast cancer

Internships/Working Experience
04/2018 – 08/2018: Bachelor Thesis and internship, Timpson Lab at the Garvan Institute of Medical Research in Sydney, Australia
04/2016 – 04/2018: Student research assistant and internship, Pfanner/Becker Lab at the Institute for Biochemistry and Molecular Biology, University of Freiburg, Germany
08/2015 – 09/2015: Internship, Wagner Lab at the Institute of Medical Microbiology and Hygiene, University Hospital Tübingen, Germany

Scientific Interests/Future Plans
The heterogenous types of cancer in their entirety are one of the deadliest diseases in our aging society and appropriate therapy is far from always available. The complexity of carcinogenesis - being at the same time live-threatening and fascinating - encourage me to get involved in cancer research. In the broad field of interacting disciplines which are all relevant in cancer biology, I am especially interested in tumour immunology and the opportunities of immunotherapy as well as cancer stem cell research. Nevertheless, it seems essential to me to reach fundamental knowledge in various research topics first, so that working in an interdisciplinary environment and the combination of findings from different approaches can be achieved later. I am passionate about science and willing to contribute to the progress of cancer research with a following PhD and academic career striving for better treatment and quality of life of cancer patients.

Contact: a.floerchinger (at) dkfz.de
LinkedIn profile

Valerie GRIESCHE (Germany)

© dkfz.de

University Education
10/2018 - present: M.Sc. Molecular Biosciences, Major Cancer Biology at Ruprecht-Karls University Heidelberg and German Cancer Research Center (DKFZ), Germany
08/2014 - 05/2018: B.Sc. Biology at Wingate University, North Carolina, USA

Highest Degree: Bachelor of Science (Biology)
Title of Bachelor Thesis
Localization of Phosphorylated AMPK during Cell Migration Using Immunofluorescence

Internships/Working Experience
08/2017 - 05/2018: "Localization of Phosphorylated AMPK during Cell Migration Using Immunofluorescence" (senior research project), Dr. Melissa Fox, Wingate University, USA
08/2016 – 05/2017: "Evaluation of mRNA Expression of AMPKα Isoforms in MCF-7 Cells Transfected with AMPKα2 and GFP Gene Plasmids" (research project), Dr. Melissa Fox, Wingate University, USA

Scientific Interests/Future Plans
Cancer is a fascinating yet dreadful disease. Even though one out of three people will be affected by cancer in the course of their lives, there is still not an ultimate cure. However, the findings of 2018 Nobel Prize winners James P. Allison and Tasuku Honjo demonstrate a promising treatment against a particular set of cancer. Releasing the breaks of the immune system by targeting checkpoint inhibitors allows the body's own defense mechanisms to attack cancer cells. Exploring cancer immunity is the future of cancer therapies. Therefore, I would love to contribute to the growing knowledge and understanding in this field during my academic career.

Contact: v.griesche (at) dkfz.de

Katia GÜNTHER (Germany)

© dkfz.de

University Education
since 2018: University of Heidelberg/DKFZ: Master's in Molecular Bioscience, Cancer Biology
2016: Semester Abroad at the University of Cape Town, South Africa
2014 - 2018: University of Tübingen: Bachelor's in Molecular Medicine

Highest Degree: Bachelor of Science in Molecular Medicine
Title of Bachelor Thesis
Development of a CRISPR/Cas9-mediated model of schizophrenia in iPSC

Internships
2018 (January-August): Research assistant and Bachelor Thesis at the Institute for Natural and Medical Sciences, Tübingen, Department: Molecular Neurobiology
2017 (January-May): Internship at the Desmond Tutu HIV Foundation, Cape Town
Main tasks included Data Analysis and Laboratory work (patient's sample collection to analysis)
2015 - 2016: Research assistant at the department of experimental and clinical Pharmacology and Toxicology at the University of Tuebingen

Scientific Interests/Future Plans
What fascinates me about cancer research is its interdisciplinarity: To tackle the multitude of diseases that are collectively referred to as 'cancer', a knowledge of the molecular basis, the genetic background, the immune system, pharmacology and much more is required. While all cancers share certain features, the varying entities, alterations in signaling pathways, drug targets and patient's prognosis make cancer an incredibly wide field in biomedical research. My aim for this Master's degree is to get an insight into the various disciplines and expand my knowledge to apply it to cancer research. I hope that this wide base of knowledge will be a good fundament to continue towards a PhD and help me decide what discipline or direction is of most interest to me.

Contact: katia.guenther (at) dkfz.de
LinkedIn profile

 

Kevin Brooks HENRY (USA)

© dkfz.de

University Education
10/2018 - Present: M.Sc. in Molecular Biosciences with Major in Cancer Biology, DKFZ/University of Heidelberg
08/2014 - 05/2018: B.Sc. in Biology, University of Minnesota - Twin Cities

Highest Degree: B.Sc. in Biology

Research/Working Experience
05/10/2016 - 01/05/2018: Undergraduate Directed Research Program, Center for Drug Design, University of Minnesota - Twin Cities; Principal Investigator: Dr. Robert Geraghty, PhD. Conducted independent research project investigating novel small molecule inhibitor binding to a viral terminase protein in human cytomegalovirus
19/02/2015 - 25/03/2016: Research Assistant, Department of Surgery, University of Minnesota - Twin Cities; Principal Investigator: Dr. Ashok Saluja, PhD
15/05/2013 - 12/01/2016: Research Assistant, Howard Hughes Medical Institute, University of Iowa; Principal Investigator: Dr. Kevin Campbell, PhD
28/05/2012 - 17/08/2012: Research Assistant, Department of Physiology and Biophysics, University of Iowa; Principal Investigator: Dr. Michael Henry, PhD

Scientific Interests/Future Plans
The astounding processes by which malignant tumors can evade the defenses of the body through equilibrium and escape stand as a stark exception to the normally controlling and watchful immune system. Understanding this delicate dance between cancer and the immune system has given us fundamental insights that have lead to incredible new technologies such as CAR-T cell therapy and T-VEC and have stoked a desire in me to contribute to this rapidly expanding field of research. Through studying at the DKFZ I aim to refine my technical proficiency and gain the knowledge necessary to make meaningful progress in the search for more effective and precise cancer therapies. After completing my Master's I would like to go on to work in the biotechnology industry and use the experience gained at the DKFZ to identify and develop effective anticancer therapies, potentially focusing on oncolytic viral immunotherapies.

Contact: k.henry (at) dkfz.de

Deniz Dilay KARAYEL (Turkey)

Akash Srivaths KOLINJIVADI RAMAKRISHNAN (India)

© dkfz.de

University Education
10/2018- present: M.Sc. in Molecular Biosciences (Major in Cancer Biology), Heidelberg University and German Cancer Research Centre, Heidelberg, Germany
07/2014- 07/2018: B.Tech. in Genetic Engineering, SRM Institute of Science and Technology (SRMIST), Chennai, India

Highest Degree: Bachelor of Technology (B.Tech) in Genetic Engineering
Title of Bachelor's Thesis
Point-of-care Detection of Disease Biomarkers Using Nanomotors

Internships/Working Experience
01/2018- 06/2018: Bachelor's thesis "Point-of-care Detection of Disease Biomarkers Using Nanomotors" in the research group of Dr. Hadi Shafiee, Division of Engineering in Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA
01/2017- 09/2017: Undergraduate Researcher at Molecular Modeling Lab, SRM Institute of Science and Technology, India. Project Title- "Insights from the Molecular Modelling and Docking Analysis of Apoptosis Inducing Factor-Nuclear Localization Signal complex to infer Nuclear Translocation of the Protein"
06/2016-07/2016: Trainee at Biozone Research Technologies Private Limited, India. Project Title- "Apoptotic Induction Potential of Petroselinum crispum and Azadirachta indica Against Melanoma"

Scientific Interests/Future Plans
Cancer has been the chief cause of mortality worldwide. The complex and intriguing nature of cancer cells never ceases to amaze me! I developed a keen interest in the modern approaches for treating cancer like gene therapy. Therefore, I believe that understanding the cellular signaling system is fundamental to identify novel therapeutic targets. I also wish to gain a deep insight on various research fields in oncology during the course of my Master's program which will serve as a foundation for pursuing a Ph.D. degree, after which I am planning to build a career in academia with an aim to improve the quality of cancer treatment.

Contact: a.kolinjivadiramakrishnan (at) dkfz.de
LinkedIn profile

Annina KURZAY (Germany)

© dkfz.de

University Education
10/2018 - present: Ruprecht-Karls-University Heidelberg and German Cancer Research Center (DKFZ), MSc. in Molecular Biosciences; Major Cancer Biology
09/2017-06/2018 University of Aberdeen, Scotland, BSc. with Honours Degree in Genetics (Immunology)
09/2015-08/2018 Bonn-Rhein-Sieg University of Applied Sciences, BSc. in Applied Biology

Highest Degrees
BSc. in Applied Biology and BSc. with Honours Degree in Genetics (Immunology)

Title of Bachelor Thesis
Evaluating the mechanism of action of a novel paclitaxel conjugate in cancer cells that express the αvβ3 integrin

Scientific Interests/Future Plans
Cancer Biology has been one of the fields I have always been fascinated to work on. For my Honours Thesis I could choose from a range of different topics and decided to work in an oncology-based lab. So, I chose this master program to gain deeper insight into the latest developments in cancer research. I am particularly interested in the abnormalities that cancer cells develop in tumours, which makes them suitable targets for new anti-cancer drugs. The development of tumour-specific agents depends on the precise discrimination between cancerous and healthy tissue, which thereby helps to reduce the systemic toxicity of current chemotherapy treatments. My future goal is to apply knowledge from basic research to novel approaches in generating anticancer drugs that cause a minimum of undesirable side effects by targeting deregulated cells only.

Contact: a.kurzay (at) dkfz.de

Tereza LAUSOVĮ (Czech Republic)

Andrew LINDSAY (Canada)

Lasse MEYER (Germany)

Anindhita Meena MURALIDHARAN (India)

Masooma RAJPUT (Pakistan)

Fabian ROSING (Germany)

Laura SCHOPPE (Germany)

© dkfz.de

University Education
10/2018 - present: M.Sc. Molecular Biosciences with Major in Cancer Biology at Ruprecht-Karls-Universität Heidelberg and German Cancer Research Center (DKFZ)
10/2015 - 09/2018: B.Sc. Biosciences at Ruprecht-Karls-Universität Heidelberg

Highest Degree: Bachelor of Science in Biosciences
Title of Bachelor Thesis
The contribution of SLM2 to alternative splicing of structural protein variants and disease related RNAs in dilated cardiomyopathy

Internships/Working Experience
09/2016-present: Student Assistant at DKFZ Heidelberg HT Sequencing Unit
03/2018-09/2018: Research Internship at Institute for Cardiomyopathies Heidelberg (ICH) at University Clinic Heidelberg Molecular Genetics Lab

Scientific Interests/Future Plans
Cancer does not emerge spontaneously, it is the result of a long process of genetic mutation, cellular malfunction, epigenetic modification, and many other processes not yet full understood. By studying cancer at the DKFZ I would like to participate in the scientific progress of resolving the details of the disease and contribute to the development of better treatment and prevention methods.
I am highly interested in the molecular processes as well as the genetic and epigenetic alterations that lead to the transformation of healthy proliferating cells to malignant ones. I am thankful for the opportunity to work at this institution, broaden my view, and get insight in the multitude of research being done here.
In the future I want to pursue a PhD and continue contributing to the field of biomedical research throughout my career.

Contact: l.schoppe (at) dkfz.de
LinkedIn profile

Öykü Ece TOSUN (Turkey)

© dkfz.de

University Education
10/2018 – Present: M.Sc. in Molecular Biosciences, with a Major in Cancer Biology at Ruprecht-Karls University Heidelberg and German Cancer Research Center (DKFZ), in Heidelberg, Germany
09/2013 – 06/2018: B.Sc. in Molecular Biology and Genetics at Middle East Technical University (METU) in Ankara, Turkey

Highest Degree: Bachelor of Science (B.Sc.) in Molecular Biology and Genetics
Title of Bachelor Project:
The Effects of Hyperglycemia on Bone Formation in vitro

Internships/Research Experience:
02/2018 – 06/2018: Undergraduate Research Assistant in the laboratory of Prof. Dr. Mesut Muyan, in the Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey
06/2017 – 08/2017: Undergraduate Research Assistant in the laboratory of Prof. Dr. John E. Davies, in the Institute of Biomaterials and Biomedical Engineering (IBBME), University of Toronto, Toronto/ON, Canada
06/2016 – 10/2016: Visiting Student Researcher in the laboratory of Prof. Dr. David L. Kaplan in the Department of Biomedical Engineering, Tufts University, Medford/MA, USA
10/2014 – 10/2015: iGEM 2015 Team Member of METU

Scientific Interests/Future Plans
Cancer is one of the most common and deadliest disease in the world. Although there are certain treatment options according to the cancer type, these options are usually harmful also for healthy tissues in patient's body and most of the times they are not enough for the complete treatment. Therefore, I would like to focus more on unusual therapeutic techniques such as oncolytic virotherapy, which specifically targets tumor cells. Moreover, my undergraduate training in molecular biology and accompanying research/internship experiences in biomaterials field increased my motivation and interest greatly on doing an interdisciplinary research. I would like to study on anti-tumor immunotherapies by using biomaterials. My ultimate goal is to pursue Ph.D. in biomedical sciences in my future career and I believe Major Cancer Biology Program in DKFZ and University of Heidelberg would provide an excellent academic ground for me to realize my goal.

Contact: o.tosun (at) dkfz.de
LinkedIn profile

Marie-Elen TUCHEL (Germany)

© dkfz.de

University Education
10/2018 – present: M.Sc. Molecular Biosciences with Major in Cancer Biology at Ruprecht-Karls University Heidelberg, Germany and German Cancer Research Center (DKFZ, Heidelberg)
10/2015 – 08/2018: B.Sc in Biochemistry at Eberhard Karls University Tübingen, Germany

Highest Degree: Bachelor of Science in Biochemistry
Title of Bachelor Thesis
Screening for novel therapeutic options to treat lymphoma

Internships/Working Experience
03/2018 – 08/2018: Bachelor thesis "Screening for novel therapeutic options to treat lymphoma" in the group of Dr. Stephan Hailfinger at the Interfaculty Institute for Biochemistry (IFIB) in Tübingen, Germany
10/2017 – 11/2017: Internship at the Department of Biochemistry – Posttranscriptional regulation of gene expression headed by Prof. Dr. Elisa Izaurralde at the Max-Planck-Institute (MPI) for developmental biology in Tübingen, Germany

Scientific Interests/Future Plans
Cancer research excites my curiosity due to the complexity it features: Cancer cells arise by various genetic and epigenetic modifications, reprogramming the cell to escape from intracellular and extracellular control mechanisms. This variety of ongoing mechanisms in cancer cells characterize cancer as an unique entity. Cancer research therefore combines a wide range of distinct research objectives, which makes it so interesting, but at the same time so challenging to investigate. Furthermore, it is the astonishing way of how tumor cells evade the immune system, which intrigues me. I am eager to gain deeper insights into the underlying molecular mechanisms of cancer cells, especially within the context of immunology, as a premise to use this fundamental knowledge to evolve new therapeutic approaches to treat cancer.
In my occupational future, I want to pursue a PhD and to continue my academic career by contributing new insights to the field of biomedical research.

Contact: m.tuchel (at) dkfz.de
LinkedIn Profile

Berk ULUĞ (Turkey)

© dkfz.de

University Education
10/2017 - present: M.Sc. in Molecular Biosciences with Major Cancer Biology at the German Cancer Research Center (DKFZ) and Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
09/2014 - 06/2018: B.Sc. in Genetics and Bioengineering at Yeditepe University, Istanbul, Turkey

Highest Degree: B.Sc. with High Honors Degree in Genetics and Bioengineering
Title of Bachelor Thesis
Role of tissue transglutaminase short isoform in the epithelial to mesenchymal transition

Internships/Working Experience
09/2017-05/2018: Bachelor Thesis "Role of tissue transglutaminase short isoform in the epithelial to mesenchymal transition", Department of Genetics and Bioengineering, Yeditepe University, Turkey, Prof. Dr. Dilek Telci
06/2017-08/2017: Visiting Scholar, Division of Biological Sciences, University of California San Diego, CA, USA, Prof. Dr. Milton H. Saier, Jr
01/2017-02/2017: Intern, Institute of Virology, Technical University of Munich / Helmholtz Zentrum München, Germany, PD Dr. rer. nat. Sabrina Schreiner
06/2016–08/2016: Intern, University Hospital of Psychiatry Zurich, University of Zurich, Switzerland, Prof. Dr. Edna Grünblatt
06/2015–07/2015: Intern, Department of Bioengineering, Ege University, Turkey, Dr. Aylin Şendemir Ürkmez

Scientific Interests/Future Plans
Biology has always been the field of science that intrigued me the most. My future was sealed when I discovered the concept of genetic engineering; I found my passion and achieved my bachelor's degree in this field. Through various internships, I observed how research is conducted in unique settings and disciplines. Because of these experiences, I have become greatly interested in cancer biology. Tragically, cancer is one of the deadliest diseases in our century. Yet, from a biological perspective, cancer is incredibly intriguing. The molecular mechanisms utilized by cancer cells to evolve and resist various therapeutics truly fascinate me. Specifically, the ways in which cellular signaling and apoptotic pathways are manipulated in cancer interests me the most. I believe that gaining a well-rounded and thorough experience at DKFZ, a leading institution and home of cutting-edge cancer research, will prepare me to be a successful scientist in the future.

Contact: b.ulug (at) dkfz.de
LinkedIn profile: https://www.linkedin.com/in/berk-ulu%C4%9F-084862ab/

Julianna Patricia VARGA (Philippines & Hungary)

© dkfz.de

University Ecuation
2015 - 2018: B.Sc. Biology (general), Ludwig-Maximilians-Universität Munich

Highest Degree: B.Sc. Biology
Title of Bachelor Thesis:
Validation of Degron Systems for Conditional Protein Depletion in Mammalian Cells

Internships
10/2018 - present: iGEM 2019 Team Heidelberg
07/2017 - 09/2017: University of Cambridge/Amgen Scholars Programme summer research project in the Sweeney Lab (Pathology Department - Virology Division) "IFIT1B: Characterising a Novel Member of the IFIT Family of Proteinsk"¯
11/2016 - 12/2017: Office assistant at the Munich Cluster for Systems Neurology

Scientific Interests/Future Plans
Biomedical science has always been of great interest to me. With the field of cancer research rapidly developing, its interdisciplinarity as well as its contribution to translational research has been on the rise; With the latter bridging the 'bench to bedside' aspect, I find it particularly rewarding to see how work in the lab can contribute to the treatment of patients.
Learning about tumour-promoting inflammation in a seminar during my bachelors, I was particularly fascinated by lymphocyte heterogeneity and their complex role in tumour progression. Hence, I would be glad to learn more regarding this relatively new research topic. However, as cancer research is a very broad field, my main goal during this masters is to develop a good basis regarding cancer biology as well as learning new techniques in the lab, making it the perfect stepping stone to a PhD.

Contact: j.varga (at) dkfz.de
LinkedIn profile

Marie WOSNY (Germany)

© dkfz.de

University Education
10/2018 - present: M.Sc. Molecular Biosciences with the Major in Cancer Biology, Ruprecht-Karls-University Heidelberg and German Cancer Research Center (DKFZ), Germany
08/2016 - 05/2017: Michigan State University, MI, USA
10/2014 - 09/2018: B.Sc. Biology Plus International, Heinrich-Heine-University Düsseldorf, Germany

Highest Degree: Bachelor of Science in Biology
Title of Bachelor Thesis
Characterization of novel p21 mRNA-binding proteins and their function in DNA‑damage induced signaling pathways

Internships
10/2018 - present: iGEM 2019 Team Heidelberg
07/2018 - 09/2018 DAAD RISE worldwide research internship, Iowa Neuroscience Institute, University of Iowa, USA, Prof. Dr. Ted Abel
01/2018 - 06/2018 Internship, Institute of Molecular Radiation Oncology, Heinrich-Heine-Universität Düsseldorf, Germany, Prof. Dr. Reiner Jänicke
07/2017 - 08/2017 Internship, Institute of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wrocław, Poland, Prof. Dr. Leon Strządała
01/2017 - 04/2017 Internship, Plant Biology Laboratories, Michigan State University, USA, Prof. Dr. Christoph Benning
08/2016 - 12/2016 Internship, Department of Animal Science, Michigan State University, USA, Prof. Dr. Paul Coussens
02/2016 - 04/2016 Internship, Institute of Metabolism and Physiology, Heinrich-Heine-Universität Düsseldorf, Germany, Prof. Dr. Eckhard Lammert
11/2015 - 01/2018 Research assistant, Institute of Botany, Heinrich-Heine-Universität Düsseldorf, Germany, Prof. Dr. Petra Bauer

Scientific Interests/Future Plans
I developed my interest in oncology because cancer is one of the most deathful diseases in industrial countries despite excellent medicine. Genomic instability fosters genetic diversity which makes cancer a heterogeneous and dynamic disease divisible into many sub-types. I want to understand the multistep process of carcinogenesis and how mutations and epigenetic modifications in the genome can enable tumor cells to escape immune destruction, to resist apoptosis and to metastasize.
The Master program "Major Cancer" and the DKFZ, a leading institution in cancer research, give me the outstanding opportunity to deepen my knowledge, to improve my acquired qualifications and to develop new skills so that I can prepare myself for pursuing a PhD. My aim is to improve cancer diagnostic tools and treatment strategies reaching for lives without cancer now and for future generations.

Contact: m.wosny (at) dkfz.de
LinkedIn profile

to top